THORNE HEALTHTECH INC - COM (THRN)

CUSIP: 885260109

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
4,780,331
Share change
-759,890
Total reported value
$17,353,296
Price per share
$3.63
Number of holders
45
Value change
-$3,910,632
Number of buys
23
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 885260109?
CUSIP 885260109 identifies THRN - THORNE HEALTHTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THORNE HEALTHTECH INC - COM (THRN) as of Q4 2022

As of 31 Dec 2022, THORNE HEALTHTECH INC - COM (THRN) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,780,331 shares. The largest 10 holders included EMERALD ADVISERS, LLC, VANGUARD GROUP INC, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Inc., BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, MYDA Advisors LLC, STATE STREET CORP, NORTHERN TRUST CORP, and Rockefeller Capital Management L.P.. This page lists 45 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.